1. Academic Validation
  2. A human sensory neuron model for varicella-zoster virus latency and reactivation in vitro

A human sensory neuron model for varicella-zoster virus latency and reactivation in vitro

  • bioRxiv. 2025 Dec 12:2025.12.12.693952. doi: 10.64898/2025.12.12.693952.
Alexander C Havelaar 1 Joseph S Flot 2 Saori Fukuda 3 Anja W M de Jong 4 R I Koning 4 Amber Schotting 1 Sem van 't Geloof 1 Tomohiko Sadaoka 3 Georges M G M Verjans 1 Paul R Kinchington 2 5 Werner J D Ouwendijk 1
Affiliations

Affiliations

  • 1 HerpeslabNL, Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
  • 2 Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, USA.
  • 3 Division of Virus Persistence & Dynamics, Center for Infectious Disease Research, Research Promotion Headquarters, Fujita Health University, Aichi, Japan.
  • 4 Electron Microscopy Facility, Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • 5 Department of Molecular Microbiology and Genetics, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract

Varicella-zoster virus (VZV) is a ubiquitous human neurotropic alphaherpesvirus that establishes lifelong latency in sensory ganglionic neurons. Subsequent viral reactivation causes herpes zoster, a morbid disease often complicated by neuropathic pain. Mechanisms underlying VZV latency and reactivation are not understood, mostly due to the lack of permissive animal models and challenges of current in vitro latency modelling. Here, we evaluated HD10.6 cells, a simplified and easily expandable human sensory neuron line to model VZV latency and reactivation. Mature HD10.6 (mHD10.6) differentiated neurons supported productive VZV Infection, viral DNA replication, production of infectious progeny, and viral spread in cultures. VZV Infection was associated with limited cytopathic effects and ultrastructural changes. Infecting mHD10.6 neurons with cell-free VZV in the presence of antivirals resulted in a quiescent-persistent state, characterized by persistent VZV genomes with restricted VZV gene expression and absence of infectious virus. Importantly, VZV could be reactivated by treatment with capsaicin, as evidenced by increased lytic viral transcription and virus spread. In conclusion, this study establishes human HD10.6 neurons as a novel and scalable in vitro model for studying VZV latency and reactivation to identify virus and host factors governing latency that may serve as therapeutic targets to restrict VZV reactivation.

Figures